Avanir Pharmaceuticals (AVNR) is +79% early on after saying a reformulated version of its Zenvia...

|About: Avanir Pharmaceuticals,... (AVNR)|By:, SA News Editor

Avanir Pharmaceuticals (AVNR) is +79% early on after saying a reformulated version of its Zenvia drug reduced the effects of pseudobulbar affect (PBA)), a condition in which patients cannot control outbursts of crying or laughing that affects two million Americans.